IGF2 and neoplasm: The IGF-I/II-neutralizing antibody m708.5 exhibited extremely high affinity to human IGF-I (KD = 15 pmol/L) and to IGF-II (KD = 9 pmol/L) as well as showed the significant anticancer activity in different human tumor cell lines through neutralizing IGFs 21.